![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, November 08, 2010 9:20:15 AM
IMGG), developer of a breakthrough medical imaging device that produces 3D
medical diagnostic images of virtually any part of the human body in real-time,
today announced the hiring of the law firm McDermott Will & Emery as an FDA
consultant.
Dean Janes, Chairman and CEO of Imaging3, commented, "We are pleased to announce
the hiring of McDermott Will & Emery as an FDA consultant and legal counsel;
management is looking forward to working with this prestigious firm to develop
our FDA filing strategy for our DViS product." "McDermott Will & Emery have the
legal, medical and scientific background along with the experience of former FDA
personnel to assist Imaging3 in building a solid strategy for a successful FDA
application," further stated Mr. Janes.
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM